| Identifiers | ||
| Product Name | Canertinib (CI-1033, PD-183805) | |
| Catalogue No. | CM726058 | |
| Description | 5 mg. Purity >99%. CAS# 289499-45-2. Canertinib (CI-1033, PD183805) effectively inhibits the growth of esophageal squamous cell carcinoma which co-expresses both EGFR and HER2 with the inhibition of phosphorylation of both MAPK and AKT. CI-1033 was highly | |
| Application | 5 mg. Purity >99%. CAS# 289499-45-2. Canertinib (CI-1033, PD183805) effectively inhibits the growth of esophageal squamous cell carcinoma which co-expresses both EGFR and HER2 with the inhibition of phosphorylation of both MAPK and AKT. CI-1033 was highly | |
| Storage Condition | -20°C | |
| Brand | Packing | Pricing | Quote request |
| IL | 5 mg | Inquiry | Ask Quote |
Advanced
Technology & Industrial Co., Ltd. all rights reserved |